Edgewise Therapeutics, Inc.

EWTXCIK 0001710072 · Every Form 4 filed by insiders at this issuer.

Filings

3

Latest Feb 9, 2024

Unique insiders

5

Showing

3 of 3

Page 1

Top insiders

Most active reporters at Edgewise Therapeutics, Inc.

NameRolesFilings
MOORE JOHN R
Officer
1
ORBIMED ADVISORS LLC
Director10% Owner
1
OrbiMed Capital GP VI LLC
Director10% Owner
1
OrbiMed Genesis GP LLC
Director10% Owner
1
Thompson Peter A.
Director10% Owner
1

All filings

3 Form 4 / 4-A filings, newest first

FiledInsiderTop transactionSharesPriceValue
Feb 9, 2024
MOORE JOHN R
General Counsel
S17,993$20.0002$359,864
Jan 25, 2024
ORBIMED ADVISORS LLC
Director · 10% Owner
P454,545$11.00$4,999,995
Jan 25, 2024
Thompson Peter A.
Director · 10% Owner
P454,545$11.00$4,999,995

Showing 13 of 3

Page 1 of 1
Real-time Form 4 intelligence. Smarter insider tracking.